Loading clinical trials...
Loading clinical trials...
Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism
Conditions
Interventions
Psilocybin
Locations
1
Canada
Centre for Addiction and Mental Health
Toronto, Ontario, Canada
Start Date
November 1, 2024
Primary Completion Date
August 1, 2027
Completion Date
August 1, 2027
Last Updated
March 20, 2026
NCT07439276
NCT07421830
NCT05066178
NCT06290258
NCT05750095
NCT05874466
Lead Sponsor
Centre for Addiction and Mental Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions